Edwards Lifesciences (NYSE:EW) will report Q2 2026 results after the July 23 close and host a 5:00 p.m. ET earnings call with webcast; ahead of the print, Mizuho reiterated an Outperform rating and nudged its price target up to $105 from $100.
Previous Week Recap
- Edwards Lifesciences Q2 2026 Results, July 23: Edwards Lifesciences (EW) will report Q2 2026 results after market close July 23, 2026; company will hold a 5:00 p.m. ET earnings call with live and archived webcast available on its IR site.
- Mizuho Upgrades EW Target To $105: Mizuho kept Edwards Lifesciences (EW) at Outperform and raised its price target to $105 from $100, a $5 increase; rating unchanged.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.